Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05300737 · ClinicalTrials.gov registry record

Symptomatic Carotid Outcomes Registry

A clinical trial of Ischemic Stroke and Carotid Stenosis, sponsored by University of Maryland, Baltimore.

Active
Registry status
114
Enrollment target
18
Study locations

NCT05300737 is a study of Ischemic Stroke and Carotid Stenosis that is active but no longer recruiting, run by University of Maryland, Baltimore. The registered enrollment target is 114 participants, below the 1,462-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (92% lower). The trial reports 18 study locations across 14 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05300737, a study of Ischemic Stroke and Carotid Stenosis, is active but no longer recruiting, sponsored by University of Maryland, Baltimore.

ACTIVE NOT RECRUITING
Registry status
114 participants
Enrollment target
18
Study locations

Study Summary

The purpose of this study is to build upon trials done over 30 years ago, which did not include statins, new antiplatelet agents, and newer antihypertensive medications. Since the landmark trials (NASCET, ECST), there have been new developments in medical stroke prevention, which creates a gap in knowledge. The aim of this study is to evaluate that clinical care with Intensive Medical Therapy (IMT) alone, the one year stroke rate in patients with symptomatic carotid stenosis and low risk clinical features will be \<5%.

Conditions Studied

Ischemic Stroke Carotid Stenosis Transient Ischemic Attack

Interventions

  • OTHER intensive medical therapy

Study Locations (18)

Illinois

  • Northwestern Memorial Hospital - Chicago
  • Rush Medical Center - Chicago

Massachusetts

  • Baystate Medical Center - Springfield
  • University of Massachusetts Medical Center - Worcester

Alberta

  • Calgary Health Sciences Center - Calgary
  • University of Alberta - Edmonton

Ontario

  • Northern Ontario School of Medicine - Greater Sudbury
  • Western University/London Health Sciences Center - London

Connecticut

  • Hartford Hospital - Hartford

Georgia

  • Emory University Hospital - Atlanta

Iowa

  • University of Iowa - Iowa City

Maryland

  • University of Maryland Medical Center - Baltimore

Trial Details

FieldValue
Enrollment Target 114 participants
Start Date 2022-08-01
Est. Completion 2026-12

Sponsor

University of Maryland, Baltimore

560 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05300737

The ClinicalTrials.gov registry entry for NCT05300737 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 114 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,462-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (92% lower). The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Ischemic Stroke appearing as the primary indexed condition, and to 1 intervention - of which intensive medical therapy is the first listed.

NCT05300737 reports 18 study locations spanning 14 distinct geographic areas - top geographies include Illinois, Massachusetts, Alberta.

Frequently Asked Questions

What is clinical trial NCT05300737 about?

NCT05300737 is a clinical study titled "Symptomatic Carotid Outcomes Registry". The purpose of this study is to build upon trials done over 30 years ago, which did not include statins, new antiplatelet agents, and newer antihypertensive medications. Since the landmark trials (NASCET, ECST), there have been new developments in medical stroke prevention, which creates a gap in kn...

What is the current status of trial NCT05300737?

This trial is currently active not recruiting. The enrollment target is 114 participants. The study started on 2022-08-01. Estimated completion is 2026-12.

What conditions does trial NCT05300737 study?

This clinical trial studies the following conditions: Ischemic Stroke, Carotid Stenosis, Transient Ischemic Attack.

What interventions are being tested in trial NCT05300737?

The interventions under investigation include: intensive medical therapy (OTHER).

Who is sponsoring clinical trial NCT05300737?

This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05300737 being conducted?

This trial has 18 study locations across Connecticut, Georgia, Illinois, Iowa, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Ischemic Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Ischemic Stroke

All registered trials for this condition

Carotid Stenosis

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.